艾瑞昔布联合关节镜清理术治疗膝骨性关节炎的效果

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (441 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Imrecoxib combined with arthroscopic debridement in the treatment of knee osteoarthritis (KOA). Methods From March 2016 to April 2018, 102 patients with KOA admitted to Dalian Second People′s Hospital of were selected as subjects. According to the random number table method, the patients were divided into the control group (arthroscopic debridement + postoperative placebo treatment, n = 51) and the observation group (arthroscopic debridement + postoperative Imrecoxib treatment, n = 51), with a course of 2 months. The clinical curative effect, joint pain visual simwlation score (VAS) and function Lysholm scors, serum interleukin 1 (IL-1), IL-1β (IL-1β) and tumor necrosis factor -α (TNF-α) levels, joint fluid in the metal matrix protease-2 (MMP-2), matrix metalloproteinases inhibitor protease 1 (TIMP-1) and metal matrix-13 (MMP-13) level changes and the incidence of adverse reactions during treatment of the two groups were compared. Results The total effective rate in the observation group was higher than that in the control group (P ＜ 0.05). VAS scores in both groups were lower after treatment than before treatment, and VAS scores in the observation group were lower than those in the control group (P ＜ 0.05). Lysholm scores in both groups were increased after treatment, and the observation group was higher than the control group (P ＜ 0.05). After treatment, IL-1 and TNF-α in both groups were lower than that before treatment, and those in the observation group were lower than those in the control group (P ＜ 0.05). After treatment, IL-1β in both groups was higher than that before treatment, and that in the observation group was higher than that in the control group (P ＜ 0.05). After treatment, MMP-2, TIMP-1 and MMP-13 in both groups were lower than that before treatment, while those in the observation group were lower than those in the control group (P ＜ 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P ＞ 0.05). Conclusion Imrecoxib combined with arthroscopic debridement is effective in the treatment of KOA, which can reduce pain, improve knee function, lower exudation of inflammatory mediators and the levels of MMP-2 and MMP-13 in articular fluid.

Key words： Imrecoxib Arthroscopic debridement Knee osteoarthritis Efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Jingliang XU Xiaofeng ZHANG Jiaguo

Cite this article:

WANG Jingliang XU Xiaofeng ZHANG Jiaguo. Effect of Imrecoxib combined with arthroscopic debridement in the treatment of knee osteoarthritis[J]. 中国医药导报, 2019, 16(27): 85-88.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2019/V16/I27/85

[1] 汪凤兰，崔颖，邢凤梅，等.农村中老年膝骨性关节炎患者自我效能水平及影响因素[J].中国老年学杂志，2014， 34（19）：5552-5554.
[2] 耿洋.关节镜清理术联合电针治疗膝骨性关节炎的临床疗效及机制初探[J].实用医院临床杂志，2018，15（1）：43-46.
[3] 唐国能，黄粹业，蒋永益，等.关节镜下有限性清理术联合透明质酸钠注射液治疗膝骨性关节炎患者近期疗效分析[J].陕西医学杂志，2018，47（7）：896-898.
[4] 高冠民，李艳敏，郑晓龙，等.艾瑞昔布和塞来昔布对中轴脊柱关节炎疗效及血清Dickopff相关蛋白1水平的影响[J].中华风湿病学杂志，2016，20（12）：836-840.
[5] 刘奕兵，王超.塞来昔布对老年膝骨性关节炎患者炎症因子、骨代谢和血液流变学指标的影响[J].中国老年学杂志，2018，38（19）：4713-4715.
[6] Zeng GQ，Chen AB，Li W，et al. High MMP-1，MMP-2，and MMP-9 protein levels in osteoarthritis [J]. Genet Mol Res，2015，14（4）：14 811-14 822.
[7] 中华医学会骨科学分会.骨关节炎诊治指南（2007年版）[J].中华骨科杂志，2007，27（10）：793-796.
[8] 张明，王铁军，刘书茂，等.玻璃酸钠对骨关节炎患者膝关节液中miR_140表达的影响[J].实用骨科杂志，2014， 20（12）：1104-1107.
[9] 付宏伟，陈晓华，马海召，等.骨疏康胶囊治疗膝骨关节炎效果及对IL-1、MMP-1、MMP-3及TIMP-1表达的影响[J].中国老年学杂志，2017，37（17）：4375-4377.
[10] 石瑛，庞坚，王翔，等.口服抗骨质增生合剂治疗膝骨关节炎的临床研究[J].中医正骨，2014，26（7）：8-12.
[11] 梁肖媚.揿针治疗早中期老年膝骨关节炎疗效观察[J].上海针灸杂志，2017，36（4）：457-459.
[12] 朱明双，许林，吕智勇，等.MRI软骨下骨髓水肿与早期膝骨关节炎临床表现的相关性研究[J].成都医学院学报，2016，11（2）：146-149.
[13] 龚韶华，匡勇，郑煜新，等.痹祺胶囊对老年性膝关节炎的疗效及基质金属酶2/基质金属酶9表达的影响[J].世界中医药，2018，13（5）：1139-1142，1147.
[14] 吴朋，徐铁锋.健脾补肾汤联合西药对膝骨性关节炎患者微炎症状态、MMP-3、MMP-9及膝关节功能的影响分析[J].陕西中医，2016，37（8）：1055-1057.
[15] 张永锋，董琪.摇旋活节手法配合中药外敷对膝骨关节炎关节镜术后患者膝关节功能恢复及生存质量的影响[J].国际中医中药杂志，2017，39（12）：1081-1084.
[16] 高冠民，张蕾蕾，郑晓龙，等.艾瑞昔布和塞来昔布治疗中轴型脊柱关节炎的随机平行对照研究[J].中华临床免疫和变态反应杂志，2017，11（3）：269-276.
[17] 郑西希，郑文洁，张奉春，等.艾瑞昔布治疗膝骨关节炎的Ⅳ期多中心开放临床试验[J].中华风湿病学杂志，2016， 20（11）：730-733.
[18] 刘晓锋，王燕妮，李晨，等.关节镜清理术联合电针治疗对膝骨关节炎患者关节液中细胞因子和蛋白酶的影响[J].海南医学院学报，2015，21（12）：1643-1645，1648.
[19] 陈建洪，吴桂红，邓莎，等.艾瑞昔布片治疗退行性膝关节炎的临床疗效观察[J].临床合理用药杂志，2016，9（16）：38-39.
[20] 黄建林，古洁若，潘云峰，等.艾瑞昔布片治疗膝骨关节炎的Ⅱ期多中心随机双盲临床试验[J].中国药学杂志，2011，46（22）：1740-1745.